Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Metformin stomach upset, including nausea, diarrhea, gas, and cramping, usually starts within the first days of treatment and eases within one to two weeks as your body adjusts, though some people notice symptoms for up to four weeks or longer. Timing depends on your dose, whether you take immediate-release or extended-release tablets, and whether you take it with food, so there are several important factors to consider before assuming it will pass on its own. Symptoms that begin suddenly after months of stable use, or that come with unusual muscle pain, weakness, or trouble breathing, are not typical adjustment side effects and need prompt attention. See below to understand the full timeline, what shortens it, and the warning signs that mean something else is going on.
Because ordinary metformin side effects and more serious problems can feel similar in the early stages, guessing is the riskiest option; a free, instant, online symptom check takes just a few minutes, helps you sort likely causes from red flags, and gives you clear next steps to discuss with your doctor.
Last reviewed for medical accuracy: 09/12/2026
Metformin is one of the most widely prescribed medications for type 2 diabetes. While it’s highly effective at lowering blood sugar and improving insulin sensitivity, it can cause gastrointestinal (GI) side effects—especially when you first start taking it. Stomach upset is the most common complaint, but understanding how long it lasts and what you can do about it will help you stay on track with your treatment plan.
Metformin works by reducing glucose production in the liver and improving how your body uses insulin. However, it can also:
Most people tolerate metformin well once their bodies adjust. The key is knowing what to expect and how to manage side effects.
Every person is different, but these general patterns emerge in clinical studies and patient reports:
First Few Days
Weeks 1–2
Weeks 3–4
Weeks 5–8
Beyond 8 Weeks
Several factors can affect how long metformin’s GI side effects last:
• Dosage
Higher daily doses (≥2,000 mg) are more likely to cause prolonged upset.
• Formulation
• Titration Schedule
Slow dose increase (e.g., adding 500 mg every 1–2 weeks) helps your body adapt.
• Food Intake
Taking metformin with meals slows absorption and reduces irritation.
• Individual Sensitivity
Your personal gut flora and digestive health play a role.
Implementing simple strategies can make a big difference:
Start Low and Go Slow
Switch to Extended-Release
Always Take with Food
Stay Hydrated
Mind Your Diet
Consider Probiotics
Split Doses
While mild GI symptoms are expected, watch for red-flag signs that require prompt attention:
• Severe, persistent diarrhea leading to dehydration
• Blood in your stool or vomit
• Signs of lactic acidosis (unusual muscle pain, rapid breathing, severe weakness)
• Jaundice (yellowing of skin or eyes)
• Sudden, severe abdominal pain
If you experience any of these, get medical care right away.
Not sure if your symptoms are within the normal range? Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help you decide whether to adjust your routine or seek urgent care.
For most people, metformin-related stomach upset peaks in the first two weeks and then gradually improves. By starting at a low dose, taking the extended-release form, and following the tips above, you can minimize discomfort and stick with this important diabetes medication.
If your symptoms persist beyond 6–8 weeks, are severe, or are accompanied by concerning signs (see “When to Be Concerned”), speak to a doctor right away. Proper management and open communication with your healthcare provider will ensure you get the blood-sugar control you need without unnecessary distress.
Remember: never stop or change your medication regimen without consulting your healthcare professional. If you ever feel that your symptoms could be life threatening or serious, seek medical attention immediately.
(References)
* Gould M, Sellin JH. Diabetic diarrhea. Curr Gastroenterol Rep. 2009 Oct;11(5):354-9. doi: 10.1007/s11894-009-0054-y. PMID: 19765362.
* Bonnet F, Scheen A. Understanding and overcoming metformin gastrointestinal intolerance. Diabetes Obes Metab. 2017 Apr;19(4):473-481. doi: 10.1111/dom.12854. Epub 2017 Feb 22. PMID: 27987248.
* Tamborlane WV, Barrientos-Pérez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, Jalaludin MY, Kovarenko M, Libman I, Lynch JL, Rao P, Shehadeh N, Turan S, Weghuber D, Barrett T, Ellipse Trial Investigators. Liraglutide in Children and Adolescents with Type 2 Diabetes. N Engl J Med. 2019 Aug 15;381(7):637-646. doi: 10.1056/NEJMoa1903822. Epub 2019 Apr 28. PMID: 31034184.
* Jones GR, Molloy MP. Metformin, Microbiome and Protection Against Colorectal Cancer. Dig Dis Sci. 2021 May;66(5):1409-1414. doi: 10.1007/s10620-020-06390-4. Epub 2020 Jun 12. PMID: 32533543.
* Frías JP, Davies MJ, Rosenstock J, Pérez Manghi FC, Fernández Landó L, Bergman BK, Liu B, Cui X, Brown K, SURPASS-2 Investigators. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021 Aug 5;385(6):503-515. doi: 10.1056/NEJMoa2107519. Epub 2021 Jun 25. PMID: 34170647.
* Nabrdalik K, Skonieczna-Żydecka K, Irlik K, Hendel M, Kwiendacz H, Łoniewski I, Januszkiewicz K, Gumprecht J, Lip GYH. Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials. Front Endocrinol (Lausanne). 2022;13:975912. doi: 10.3389/fendo.2022.975912. Epub 2022 Sep 14. PMID: 36187122; PMCID: PMC9524196.
* Huang X, Sun T, Wang J, Hong X, Chen H, Yan T, Zhou C, Sun D, Yang C, Yu T, Su W, Du W, Xiong H. Metformin Reprograms Tryptophan Metabolism to Stimulate CD8+ T-cell Function in Colorectal Cancer. Cancer Res. 2023 Jul 14;83(14):2358-2371. doi: 10.1158/0008-5472.CAN-22-3042. PMID: 37195082.
* Huang Y, Wang F, Lin X, Li Q, Lu Y, Zhang J, Shen X, Tan J, Qin Z, Chen J, Chen X, Pan G, Wang X, Zeng Y, Yang S, Liu J, Xing F, Li K, Zhang H. Nuclear VCP drives colorectal cancer progression by promoting fatty acid oxidation. Proc Natl Acad Sci U S A. 2023 Oct 10;120(41):e2221653120. doi: 10.1073/pnas.2221653120. Epub 2023 Oct 3. PMID: 37788309; PMCID: PMC10576098.
* Li X, Xiang Z, Wang X, He H, Xu M, Tan C, Wu X, Zhang J, Dong W. Metformin attenuates colitis via blocking STAT3 acetylation by reducing acetyl-CoA production. J Adv Res. 2026 Jan;79:393-407. doi: 10.1016/j.jare.2025.03.058. Epub 2025 Mar 31. PMID: 40174640; PMCID: PMC12766235.
* Pan F, Wang Y, Lim YZ, Urquhart DM, Estee MM, Wluka AE, Wolfe R, Cicuttini FM. Metformin for Knee Osteoarthritis in Patients With Overweight or Obesity: A Randomized Clinical Trial. JAMA. 2025 May 27;333(20):1804-1812. doi: 10.1001/jama.2025.3471. PMID: 40274279; PMCID: PMC12022862.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.